SEC Form 4 · accession 0001225208-18-016751

Edwards Lifesciences Corp · EW

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Donald E Bobo Jr.

Officer — CVP,Strategy/Corp Development

Period of report

Dec 12, 2018

Accepted (ET)

Dec 17, 2018 · 6:20 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001099800

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F2	Dec 12, 2018	M	5,500	$42.725	A	24,482	D
Common Stock	Dec 12, 2018	S	5,500	$164.99	D	18,982	D
Common Stock^F3	holding	—	—		—	12,550	I	401(k)
Common Stock^F4	holding	—	—		—	176	I	By Son
Common Stock	holding	—	—		—	46,832	I	By Trust

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (Right to Acquire)	$42.725	Dec 12, 2018	M	5,500	D	May 9, 2012	May 8, 2019	Common Stock	5,500	17,100	D

Explanation of responses

F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2018.
F2Amount reflects (i) approximately 831 shares less which were previously reported as directly held by Insider but are not attributable to Insider and (ii) an additional 176 shares less which were previously reported as directly held by Insider but are held by Insider's son (see footnote (4) below).
F3Amount reflects shares as represented on the most recent statement of Issuer's 401(k) Plan Administrator.
F4Amount reflects shares that were previously reported as directly held but are indirecty held by Insider through Insider's son.

Remarks

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.